Healthcare technology firm Semler Scientific has recently disclosed significant paper losses on its investment in Bitcoin for the first quarter of the year. The firm reported an unrealized loss of approximately $41.8 million from its cryptocurrency holdings, as Bitcoin prices experienced a notable correction.
According to a filing with the Securities and Exchange Commission on April 15, Semler holds a total of 3,182 Bitcoin (BTC), valued at approximately $263.5 million as of March 31. During the first quarter, Bitcoin’s price fell by 12%, moving from $93,500 at the beginning of January to $82,350 at the end of March. This decline is part of a wider correction, with prices dropping as much as 32% from their all-time high earlier in the year.
Despite these losses, Semler remains unwavering in its commitment to acquiring Bitcoin. CEO Doug Murphy-Chutorian emphasized the firm’s laser focus on this cryptocurrency while continuing to support growth and innovation in the healthcare sector. Furthermore, Semler is recognized as the twelfth largest corporate holder of Bitcoin, surpassing international gaming firms in Bitcoin acquisition.
To support its Bitcoin acquisition strategy, Semler has announced its intentions to float a $500 million stock sale. The firm outlined its plans in a separate April 15 SEC filing, indicating that it may offer and sell securities valued up to this amount. “We may offer and sell securities from time to time in one or more offerings,” the filing stated. It is worth noting that Semler’s stock is currently listed on Nasdaq under the ticker SMLR.
The decision to initiate a stock sale comes amidst a challenging financial landscape for Semler; the firm reported expected revenues in the range of $8.8 to $8.9 million and operational losses of approximately $1.3 to $1.5 million for the same period. Furthermore, Semler disclosed it holds around $10 million in cash and cash equivalents as of March 31.
Amidst this backdrop, Semler’s shares have seen a 36% decline in their value since the beginning of 2025, underlining the volatility surrounding its stock price and operations. The company has cautioned investors about ongoing market volatility, which may impact its share performance moving forward.
Investors and stakeholders are urged to keep a close watch on Semler’s moves in both the Bitcoin and medical device markets. With the planned stock sale, the firm aims not only to cover its current operational losses but also to secure new investments in Bitcoin, reinforcing its commitment to cryptocurrency as a key component of its corporate strategy.
In summary, Semler Scientific’s current financial situation highlights the unpredictable nature of Bitcoin investments and the ongoing challenges faced by businesses that venture into cryptocurrency. As Semler continues to navigate these turbulent waters, its future strategies will undoubtedly be crucial in determining its long-term success in both healthcare and cryptocurrency markets.
